Randomized Double-blind Cost-effectiveness Comparison of Two 10% Urea Creams in Patients with Diabetic Foot Syndrome.
Adv Skin Wound Care
; 37(5): 1-7, 2024 May 01.
Article
em En
| MEDLINE
| ID: mdl-38648245
ABSTRACT
OBJECTIVE:
To evaluate the cost-effectiveness of two 10% urea creams in patients with diabetic foot syndrome.METHODS:
This was a prospective, longitudinal, single-center, randomized, double-blind, prospective clinical trial that evaluated the skin quality of 20 feet belonging to 10 patients with diabetic foot syndrome after the application of two 10% urea creams purchased from pharmacies and supermarkets.RESULTS:
At follow-up, 19 (95%) of the participants' feet showed improved skin quality, irrespective of the cream applied. On visual inspection, participants had a decreased presence of xerosis, hyperkeratosis, and preulcerative signs such as subkeratotic bruising and areas of redness on the dorsum of the toes. At the 3-month follow-up, nine (90%) of the participants stated that they had continued to apply the cream as a method of self-management to prevent complications.CONCLUSIONS:
Creams containing 10% urea purchased in supermarkets improve foot skin quality in patients with diabetic foot syndrome, regardless of their cost. Based on these findings, the authors recommend creams containing 10% urea as a self-management tool for patients with diabetic foot syndrome.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Ureia
/
Análise Custo-Benefício
/
Pé Diabético
/
Creme para a Pele
Limite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article